(Q40981121)

25 September 2017

1 reference

title

Metastatic renal cell carcinoma to ampulla of Vater: an unusual lesion amenable to surgical resection (English)

1 reference

metastatic renal cell carcinoma

25 September 2017

main subject

1 reference

1 reference

Leslie KA

1

1 reference

25 September 2017

Tsao JI

series ordinal

2

1 reference

25 September 2017

Rossi RL

series ordinal

3

1 reference

25 September 2017

Braasch JW

series ordinal

4

1 reference

25 September 2017

language of work or name

1 reference

1 March 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

119

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

349-351

1 reference

Late presentation of metastatic renal cell carcinoma as a bleeding ampullary mass

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980122-X

7 January 2021

Obstructive jaundice caused by metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980122-X

7 January 2021

Ampullary tumor caused by metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980122-X

7 January 2021

Solitary Metastasis from Renal Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980122-X

7 January 2021

The Surgical Management of Renal Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980122-X

7 January 2021

Pancreatic metastases of renal cell carcinoma: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980122-X

7 January 2021

Aggressive versus conservative management of stage IV renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980122-X

7 January 2021

Prognostic factors in metastatic renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980122-X

7 January 2021

Phase II trial of high-dose intermittent interleukin-2 in metastatic renal cell carcinoma: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980122-X

7 January 2021

Subcutaneous interleukin-2 plus interferon alfa-2a in metastatic renal cancer: an outpatient multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6060%2896%2980122-X

7 January 2021

10.1016/S0039-6060(96)80122-X

Identifiers

DOI

1 reference

25 September 2017

1 reference